Published in Clin Imaging on February 03, 2010
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Adult intestinal intussusception: CT appearances and identification of a causative lead point. Radiographics (2006) 3.22
Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73
In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62
A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res (2003) 2.55
Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem (2002) 2.45
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. Radiology (2007) 2.29
Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology (2007) 2.26
Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc Natl Acad Sci U S A (2010) 2.20
Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell (2012) 2.16
Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 2.12
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med (2008) 2.06
Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. Radiology (2004) 2.01
A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. J Clin Invest (2008) 1.69
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res (2004) 1.67
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology (2004) 1.62
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg (2008) 1.56
In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum (2004) 1.55
Case records of the Massachusetts General Hospital. Case 10-2012. A 16-year-old boy with epigastric pain and a mediastinal mass. N Engl J Med (2012) 1.54
Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation. Clin Cancer Res (2013) 1.53
Novel multiwavelength microscopic scanner for mouse imaging. Neoplasia (2005) 1.52
Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A (2004) 1.51
Miniaturized multichannel near infrared endoscope for mouse imaging. Mol Imaging (2003) 1.45
Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology (2007) 1.45
Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med (2007) 1.44
Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42
ACR Appropriateness Criteria® Multiple gestations. Ultrasound Q (2012) 1.40
Current concepts in lymph node imaging. J Nucl Med (2004) 1.38
Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer (2006) 1.38
ACR Appropriateness Criteria® clinically suspected adnexal mass. Ultrasound Q (2013) 1.38
Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics (2002) 1.36
Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. Gynecol Oncol (2009) 1.35
Simultaneous fluorescence imaging of protease expression and vascularity during murine colonoscopy for colonic lesion characterization. Gastrointest Endosc (2006) 1.34
Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia (2006) 1.33
Upconverting luminescent nanomaterials: application to in vivo bioimaging. Chem Commun (Camb) (2009) 1.30
Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis. Cancer Prev Res (Phila) (2009) 1.27
In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia (2006) 1.24
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22
Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia. Am J Hematol (2006) 1.20
Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol (2011) 1.20
Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther (2005) 1.19
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis. EMBO Mol Med (2014) 1.19
Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol (2002) 1.16
Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest (2005) 1.14
Small bowel CT fat density target sign in chronic radiation enteritis. Australas Radiol (2003) 1.12
Percutaneous imaging-guided abdominal and pelvic abscess drainage in children. Radiographics (2004) 1.10
Noninvasive optical detection of bone mineral. J Bone Miner Res (2007) 1.10
Multiparametric magnetic resonance imaging of prostate cancer. Indian J Radiol Imaging (2012) 1.09
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma. Int J Radiat Oncol Biol Phys (2009) 1.09
Real-time multichannel imaging framework for endoscopy, catheters, and fixed geometry intraoperative systems. Mol Imaging (2007) 1.09
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin. Clin Cancer Res (2008) 1.09
Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology (2008) 1.08
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Improved in vivo whole-animal detection limits of green fluorescent protein-expressing tumor lines by spectral fluorescence imaging. Mol Imaging (2007) 1.07
N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption. Mol Cell Biol (2006) 1.06
Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum (2007) 1.06
Added value of selected images embedded into radiology reports to referring clinicians. J Am Coll Radiol (2010) 1.05
Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography. J Biomed Opt (2010) 1.05
In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate. Atherosclerosis (2010) 1.04
Adult intestinal intussusception: can abdominal MDCT distinguish an intussusception caused by a lead point? Abdom Imaging (2008) 1.04
Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors. Stem Cells (2013) 1.03
Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. Mol Imaging (2003) 1.03
In vivo quantitative microvasculature phenotype imaging of healthy and malignant tissues using a fiber-optic confocal laser microprobe. Transl Oncol (2008) 1.02
Interventional optical molecular imaging guidance during percutaneous biopsy. Radiology (2014) 1.02
Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor. Cancer Res (2005) 1.00
Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus. Cancer Res (2003) 1.00
Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo. Bone (2008) 1.00
Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol (2010) 0.99
Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study. Am J Nucl Med Mol Imaging (2013) 0.98
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging (2009) 0.98
Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2. Hum Gene Ther (2006) 0.97
A novel mouse model for segmental orthotopic colon cancer. Int J Cancer (2005) 0.96
MRI in patients with inflammatory bowel disease. J Magn Reson Imaging (2011) 0.95
Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy. Theranostics (2012) 0.94
Systems-level modeling of cancer-fibroblast interaction. PLoS One (2009) 0.94
Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo. Cancer Res (2007) 0.93
Optical molecular imaging and its emerging role in colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2010) 0.92
Design and demonstration of a small-animal up-conversion imager. Opt Express (2008) 0.92
Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function. Arthritis Rheum (2009) 0.92
Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas. Cancer Res (2002) 0.91
Quantitative endovascular fluorescence-based molecular imaging through blood of arterial wall inflammation. Radiology (2009) 0.91
Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology (2012) 0.91
Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol (2006) 0.91
ACR appropriateness Criteria® first trimester bleeding. Ultrasound Q (2013) 0.91
Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization. Cancer Res (2013) 0.90
Detecting active inflammation and fibrosis in pediatric Crohn's disease: prospective evaluation of MR-E and CT-E. Abdom Imaging (2013) 0.90
Metformin--an adjunct antineoplastic therapy--divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging. J Nucl Med (2013) 0.89
Pediatric inflammatory bowel disease: imaging issues with targeted solutions. Abdom Imaging (2015) 0.88
Imaging of pediatric patients with inflammatory bowel disease. AJR Am J Roentgenol (2012) 0.88
The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol (2013) 0.88
Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology (2008) 0.88
Prospective trial with optical molecular imaging for percutaneous interventions in focal hepatic lesions. Radiology (2014) 0.88
Relationship between radiologist training level and fluoroscopy time for voiding cystourethrography. AJR Am J Roentgenol (2013) 0.88
Overview of nanoparticle use in cancer imaging. Cancer Biomark (2009) 0.87